Immucell (ICCC) Return on Equity (2016 - 2025)
Historic Return on Equity for Immucell (ICCC) over the last 15 years, with Q3 2025 value amounting to 0.08%.
- Immucell's Return on Equity rose 2300.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.08% for FY2024, which is 1300.0% up from last year.
- Latest data reveals that Immucell reported Return on Equity of 0.08% as of Q3 2025, which was up 2300.0% from 0.06% recorded in Q2 2025.
- In the past 5 years, Immucell's Return on Equity registered a high of 0.08% during Q3 2025, and its lowest value of 0.24% during Q3 2023.
- Its 5-year average for Return on Equity is 0.08%, with a median of 0.05% in 2021.
- Its Return on Equity has fluctuated over the past 5 years, first plummeted by -2200bps in 2023, then surged by 2300bps in 2025.
- Over the past 5 years, Immucell's Return on Equity (Quarter) stood at 0.0% in 2021, then crashed by -3222bps to 0.08% in 2022, then crashed by -183bps to 0.23% in 2023, then skyrocketed by 65bps to 0.08% in 2024, then soared by 197bps to 0.08% in 2025.
- Its Return on Equity stands at 0.08% for Q3 2025, versus 0.06% for Q2 2025 and 0.01% for Q1 2025.